How people choose in this industry
The ordering doctor is the buyer. Oncologists, fertility specialists, neurologists, paediatricians and pathologists look at the test menu and the clarity of the report. They also ask whether a scientist is available to discuss a result, and whether sample transport is reliable. Patients rarely choose; they pay for what the doctor orders.
Trust builds through education. Doctors respond to a short, clear explanation of when a test is useful, what the result means and how it changes treatment. Conference presence, case discussions and a visit from someone who understands the science matter far more than brochures.
Logistics decide repeat orders. Collection pick-up, cold chain, report format and the response when a sample is queried either earn the next sample or lose it. A lab that makes the doctor's life easy keeps the account.
The decision before implementation
The owner approves segment priorities and commercial boundaries before the team changes its approach.
Existing industry priorities to review
- Cancer panels and tumour markers
- Prenatal and carrier screening
- Fertility and reproductive genetics
- Newborn and metabolic screening
- Rare disease and exome testing
These describe the industry's wider priorities. The written scope identifies which this service will address.